scholarly journals Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy

2021 ◽  
Author(s):  
Thomas Zegkos ◽  
Georgios Tziomalos ◽  
Despoina Parcharidou ◽  
Dimitris Ntelios ◽  
Christos A. Papanastasiou ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Sudden Cardiac Death ◽  
Risk Stratification ◽  
Cardiac Death ◽  
American Heart Association ◽  
American Heart ◽  
Heart Association

scholarly journals CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)

2013 ◽  
Vol 12 (1) ◽  
pp. 73-79
Author(s):  
E. V. Privalova ◽  
V. Yu. Kaplunova ◽  
N. V. Khabarova ◽  
G. A. Shakaryants ◽  
Yu. N. Belenkov
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Sudden Cardiac Death ◽  
Risk Stratification ◽  
Cardiac Death ◽  
Therapeutic Strategy ◽  
Heart Association ◽  
Preventive Treatment ◽  
Risk Levels ◽  
Life Saving ◽  
Clinical Scenarios

One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD risk. The available clinical evidence suggests that SCD risk stratification is an effective algorithm for determining the need for preventive treatment. The latter should be individualised, based on the risk levels in each patient. 

Sign in / Sign up

Export Citation Format

Share Document